EGFR and cancer: Since IL-1 can also trigger cancer cell death [98, 99], the linked tumorilytic and acnegenic effects of EGFR blockade in such patients could reflect the same mechanism: namely, loss of negative feedback by (active) EGFR, leading by default to bypass upregulation of FGFR2b [100].